Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Vinay Prasad

Chaos at the FDA leaves staffers disturbed, ready to leave

Questions over reliability have risen over the underperforming and dysfunctional FDA.

Axios

FDA Outlines Process To Speed Up Rare Disease Therapy Approvals

The U.S. Food and Drug Administration on Thursday introduced the Rare Disease Evidence Principles (RDEP) to provide greater speed and predictability in the review of therapies intended to treat rare diseases with very small patient populations.

Benzinga

FDA Official Pressures YouTube Into Removing a Channel For Posting His Own Vaccine Comments

Not long ago, conservatives were rightly concerned about jawboning. Now they're apparently happy to take part in it themselves.

Reason

From analysis to the latest developments in health,
read the most diverse news in one place.

Over 1,000 HHS staffers demand RFK Jr resign as civil war swirls over his remaking of the agency

Employees past and present come togther to express lack of confidence in Robert F Kennedy Jr over turbulent leadership of America’s public health institutions

The Independent UK

Top FDA official demands removal of YouTube videos in which he criticized Covid vaccines

Channel was an attempt to ‘preserve’ what officials in current Trump administration said during the pandemic

The Guardian - US

MAGA firebrand Laura Loomer breaks with Trump in rare public spat over 600k China student visas: ‘Do the math’

Loomer, who has the ear of the president, criticized him after he hailed the ‘very important relationship’ with Beijing

The Independent UK

RFK Jr denies 2028 presidential ambitions after attacks from Trump influencer Laura Loomer

HHS chief took to social media with deference to president after ‘Trump’s Rasputin’ said he was plotting move

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Laura Loomer sets her sights on her next target to get the boot from the Trump administration

‘I’m not naive enough to think that the president is going to get rid of RFK, but I will say that … there are concerns about some of the staffing decisions over at HHS,’ Laura Loomer said this week.

The Independent UK

Ousted FDA vaccine chief Vinay Prasad is returning to the agency

A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency’s top vaccine regulator

The Independent UK

Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction

In a stunning reversal, Dr. Vinay Prasad is returning to his role as director of the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER), just days after his resignation.

Benzinga

Trump news at a glance: Lutnick threatens Harvard patents; former Fox commentator bound for UN

Commerce secretary begins process could let the government seize Harvard patents; Tammy Bruce nominated for deputy US ambassador to UN – key US politics stories from 9 August 2025

The Guardian - AU

Vinay Prasad returns to FDA days after leaving under pressure from Laura Loomer

Prasad left the agency after far-right influencer released edited audio misleadingly suggesting he was anti-Trump

The Guardian - US

Laura Loomer names the MAGA rep she says the Trump admin ‘can’t stand’

Loomer testifies in HBO lawsuit deposition that a high-profile congresswoman is disliked, despite her outspoken loyalty to the president

The Independent UK

Laura Loomer says a friend calls her ‘Trump’s Rasputin’ as her surprising influence grows in White House

Right-wing conspiracy theorist, 32, says she told president he has a ‘vetting crisis’ in his administration

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Laura Loomer’s MAGA critics accuse her of being funded by Big Pharma

‘I do not work for Big Pharma. I work in support of President Trump on the outside of the administration,’ Loomer tells The Independent

Benzinga

Why Is Replimune Stock Trading Lower On Monday?

On Monday, Replimune Group Inc. (NASDAQ:REPL) is reeling after the FDA unexpectedly rejected its skin cancer treatment, triggering a stock plunge and a wave of investor outrage.

We Got This Covered

Laura Loomer just admitted she’s running a ‘tip line’ to get Trump officials fired and predicts ‘hundreds’ more pink slips

Loomer's purge machine.

We Got This Covered

‘Progressive leftist saboteur’: How Laura Loomer’s single-handely got Donald Trump’s choice fired

Loomer's latest victory.

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times UK

Vinay Prasad vs the FDA: How One Doctor's Policies Collided with Politics and Cost Him His Job

Vinay Prasad resigns from the FDA after backlash over vaccine restrictions and gene therapy decisions. Political pressure cited in sudden departure.

Benzinga

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

In May, FDA Commissioner Marty Makary named Vinay Prasad the next director of the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER). Within three months, Prasad resigned.

The Guardian - US

FDA’s top vaccine official leaves post after less than four months

Trump administration gives no details about reason for departure of Vinay Prasad, but he had critics and had taken unusual actions

The Independent UK

FDA names former pharmaceutical company executive to oversee US drug program

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program

The Guardian - US

‘Tremendous uncertainty’ for cancer research as US officials target mRNA vaccines

Amid Trump cuts and state-level backlash, experts worry that progress in messenger RNA vaccines could stall

Benzinga

FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months

The U.S. Food and Drug Administration (FDA) has approved Moderna Inc.’s (NASDAQ:MRNA) supplemental Biologics License Application (sBLA) for Spikevax, the company’s COVID-19 vaccine, in children six months through 11 years of age who are at increased risk for COVID-19 disease.

The Independent UK

FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines

1 2 3

People

Marjorie Taylor Greene

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.